PAT Selective Implementation Advised As Cost Control Measure
This article was originally published in The Tan Sheet
Executive Summary
The cost to pharmaceutical manufacturers of operating process analytical technology often is more than the cost of implementing it, according to Pfizer Drug Product Technology Senior Manager Joep Timmermans